ANITA MADAN ET AL: "Intrathecal Baclofen Therapy Slows Progressive Disability in Multiple System Atrophy", NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE, vol. 14, no. 2, March 2011 (2011-03), pages 176-178, XP055062528, ISSN: 1094-7159, DOI: 10.1111/j.1525-1403.2011.00336.x (B1)

EP-A1- 2 322 163 (B1)

EP-A2- 0 467 710 (B1)

FOX S H ET AL: "Non-dopaminergic treatments in development for Parkinson's disease", LANCET NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, vol. 7, no. 10, October 2008 (2008-10), pages 927-938, XP025428983, ISSN: 1474-4422, DOI: 10.1016/S1474-4422(08)70214-X [retrieved on 2008-09-15] (B1)

WO-A2-02/056892 (B1)

LINAZASORO G ET AL: "Pharmacological treatment of Parkinsonâ s disease: life beyond dopamine D2/D3 receptors?", JOURNAL OF NEURAL TRANSMISSION ; BASIC NEUROSCIENCES, GENETICS AND IMMUNOLOGY, PARKINSON'S DISEASE AND ALLIED CONDITIONS, ALZHEIMER'S DISEASE AND ADOLESCENT PSYCHIATRY RELATED DISORDERS, BIOLOGICAL PSYCHIATRY, BIOLOGICAL CHILD AND ADOLESCENT PSYCHIAT, vol. 115, no. 3, 11 February 2008 (2008-02-11), pages 431-441, XP019592403, ISSN: 1435-1463 (B1)

V. V. MYLLYLA ET AL: "Role of selegiline in combination therapy of Parkinson's disease", NEUROLOGY, vol. 47, no. Issue 6, Supplement 3, December 1996 (1996-12), pages 200S-209S, XP055062612, ISSN: 0028-3878, DOI: 10.1212/WNL.47.6_Suppl_3.200S (B1)

WO-A1-2009/133128 (B1)

JIMENEZ-SHAHED J ET AL: "Acamprosate Improves Impulse Control Disorders in Parkinson's Disease", NEUROLOGY, vol. 70, no. 11 Suppl 1, March 2008 (2008-03), page A288, XP055062517, 60TH ANNUAL MEETING OF THE AMERICAN-ACADEMY-OF-NEUROLOGY; CHICAGO, IL, USA (B1)